Conferences

12–13 June 2017, Hotel Palace, Berlin, Germany
Oxford Global’s - 18th Annual Drug Discovery Leaders’ Summit

This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field. 

 

8 interactive streams: 

  • Drug Discovery Innovation and Strategies, Enabling Technologies
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Medicinal Chemistry and Drug Design: Novel Approaches.

Agenda: http://bit.ly/2dUjWB5

Free Pre-Congress Webinars

Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today

Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today

Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today

For further information on the congress and the webinars, please contact Guillaume Alonso on [email protected] or call +44 (0) 1865 248 455.

http://bit.ly/2dUjWB5

Back to TopTop